Survivin (80-88)

Survivin (80-88) is a synthetic peptide corresponding to amino acids 80 through 88 of the human Survivin protein, an inhibitor of apoptosis (IAP) family member that plays a pivotal role in cell division and the regulation of programmed cell death. As a peptide fragment derived from a highly conserved region of Survivin, this compound serves as a valuable research tool for investigating protein-protein interactions, immune recognition, and cellular signaling pathways associated with cell survival and proliferation. Its sequence specificity and functional relevance make it particularly significant for studies focused on apoptosis regulation, tumorigenesis, and the development of molecular probes or analytical assays targeting Survivin-mediated cellular processes.

Epitope mapping: Researchers frequently utilize the 80-88 peptide fragment to delineate immunogenic regions within the Survivin protein. By employing this peptide in binding assays or immunological screening, scientists can systematically identify T-cell or antibody epitopes, advancing the understanding of immune recognition mechanisms. Such mapping is essential for characterizing the specificity of immune responses against Survivin, which is often overexpressed in various cancer cell lines, thereby supporting the rational design of immunological reagents and experimental models.

Immunological assay development: The Survivin (80-88) peptide is commonly incorporated as a reference antigen in assays designed to monitor cellular immune responses. In particular, it serves as a positive control or stimulatory peptide in ELISPOT, flow cytometry, and cytotoxicity assays that measure T-cell activation or cytokine production. These applications are crucial for evaluating immune cell recognition of Survivin-derived epitopes, validating assay performance, and standardizing experimental protocols in immunological research.

Peptide-based functional studies: Investigators employ this peptide to probe the functional consequences of Survivin-derived sequences on cellular signaling and apoptosis pathways. By introducing the peptide into cultured cells or biochemical systems, it is possible to assess its impact on caspase activity, protein-protein interactions, or downstream signaling events. Such studies contribute to elucidating the mechanistic role of Survivin fragments in modulating cell fate decisions and provide insights into the molecular determinants of apoptosis inhibition.

Antigen presentation research: The Survivin (80-88) peptide is instrumental in studies focused on major histocompatibility complex (MHC) binding and antigen processing. By assessing the peptide's affinity for specific MHC molecules, researchers can explore the parameters governing antigen presentation, T-cell receptor recognition, and the generation of peptide-MHC complexes. This line of investigation is foundational for understanding how Survivin-derived antigens are processed and displayed on the cell surface, with implications for basic immunology and the development of peptide-based research tools.

Analytical standards and assay controls: As a chemically defined peptide, Survivin (80-88) is frequently employed as a standard or control in quantitative and qualitative analytical techniques, such as mass spectrometry, high-performance liquid chromatography (HPLC), and immunoassays. Its use ensures consistency, reproducibility, and accuracy in experimental setups that require rigorous validation of peptide detection or quantification methodologies. By providing a reliable benchmark, the peptide supports quality assurance and methodological optimization in diverse biochemical research environments.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency